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Abstract 
Sebaceous carcinoma (SC) is an uncommon neoplasm manifesting itself either in the eyelid 
or extraocularly in the head and neck area. Surgery is the standard of care. Irradiation is 
rarely proposed as monotherapy but is frequently administered as an adjuvant regimen 
following surgical resection. There is no known strategy concerning chemotherapeutic 
treatment in highly aggressive recurrent – or metastatic – forms of the disease. Our patient 
presented with an aggressive SC of the scalp recurring after multiple excisions and local 
radiotherapy. Chemotherapy with 5-fluorouracil, cisplatin and docetaxel was then initiated; 4 
cycles were administered, followed by capecitabine maintenance. Shortly after starting 
chemotherapy, dermal lesions had completely disappeared and radiological response could 
be seen. The patient experienced an extended period (>20 months) of complete remission. In 
this report, we show an excellent response of a highly aggressive SC after a combination of 
chemotherapy as for head and neck cancers. © 2014 S. Karger AG, Basel 
Introduction 
Sebaceous carcinoma (SC) is a rare malignant tumor originating from adnexal skin 
structures. Most of these malignancies develop in the head and neck area, notably in the 
eyelid. Other sites include the parotid and submandibular glands, the external auditory 
canal, the trunk or the limbs [1]. Tumors of this type commonly reveal a diffuse and invasive 
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growth pattern and are associated with a high incidence of locoregional recurrence in the 
skin and lymph nodes but also with distant metastases [2]. Repeated surgical excisions and 
lymph node dissections remain the standard of care whenever involvement is suspected [3]. 
Retrospective studies have reported an overall 5-year survival of approximately 70% 
regardless of where the primary tumors had been located [1]. The risk of regional and 
distant metastases increases in tumors with poorly differentiated histology and deep 
invasion or being >3 cm in size [2]. The ideal approach to deal with multiple locoregional or 
distant metastasis is currently unknown. In this article, we report on a patient who 
presented with highly aggressive SC of the scalp, which continued to progress both with 
multiple skin nodules and with lymph node metastases, even though multiple excisions and 
radiotherapy had been performed. Complete remission was obtained with a combination 
regimen of 5-fluorouracil, cisplatin and docetaxel. 
Case Report 
A 69-year-old Caucasian male with a history of multiple premalignant skin lesions pre-
sented with a solitary 15-mm erythematous nodular dermal lesion on the vertex. A wide 
surgical excision was performed and revealed a poorly differentiated SC. In the following 
months, 2 new dermal lesions consecutively appeared in the right occipital area. As the local 
resections were microscopically incomplete, a strategy including wide surgical excision with 
skin graft reconstruction and right posterior cervical lymphadenectomy was adopted. The 
pathological examination confirmed that the SC had spread to the lymph nodes and that 
positive tumor margins were still present in the skin and gave rise to multiple new 
recurrences. More excisions were performed over the next few months, each being followed 
by more recurrences within a month’s time. 
Irradiation in the form of tomotherapy was then proposed. A total of 66 Gy was applied 
to the occipital and right retroauricular areas, and 52.8 Gy to the cervical lymph nodes. No 
benefit was observed after radiotherapy and the lesions continued to grow. A physical 
examination performed at that time revealed an excoriated hemorrhagic nodular dermal 
lesion (3 × 4 cm) in the central parieto-occipital region and a second nodular lesion (3 × 2 
cm) in the right retroauricular area (fig. 1a). Magnetic resonance imaging of the head 
showed 3 subcutaneous masses (3 × 2 cm) in the occipital area, the right retroauricular 
region and the right parietal zone (fig. 2a). No intracerebral lesions were observed. Further 
radiographic studies indicated the presence of lymph node metastases in the absence of 
distant metastases. 
At this point, chemotherapy was initiated using a combination of 5-fluorouracil (750 
mg/m2/day for 4 days), cisplatin (100 mg/m2) and docetaxel (75 mg/m2) every 3 weeks. A 
significant clinical improvement (>50% reductions in the size of the lesions) was already 
seen after the first cycle. Due to myelosuppression, the decision was made to remove 
docetaxel from the regimen. After a total of 4 chemotherapy cycles, all lesions had disap-
peared. Treatment was subsequently maintained with single-agent capecitabine (1,000 
mg/m2/day) on days 1–10 every 21 days. A clinical and radiographic follow-up at >20 
months confirmed that complete remission had persisted (fig. 1b, fig. 2b). 
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Discussion 
SC are uncommon cutaneous neoplasms originating from adnexal structures of the skin. 
They are predominantly treated by surgical means, with Mohs micrographic surgery being 
preferred for ocular varieties [4] and surgical resection with wide healthy margins for 
extraocular varieties. Complementary treatment options such as cryotherapy, local 
mitomycin-C instillation and radiotherapy have been used in selected cases [5, 6]. 
SC are considered to be potentially aggressive, with local recurrence rates ranging from 
11 to 23% [3, 4, 7]. Regional and distant metastases have been reported in up to 21% of 
cases [5]. Historical evidence has suggested that ocular SC may evolve more rapidly than 
extraocular SC [2, 8]. However, these findings have not been unanimously confirmed in more 
recent series. Indeed, there have been reports of highly aggressive and extensively 
disseminating extraocular SC [9, 10]. 
Regional lymphadenectomy also plays an important role in the management of SC since 
lymph node involvement is seen in approximately 15–21% of cases [5]. One study revealed a 
high rate (60%) of occult nodal metastases after elective regional lymph node dissection [3]. 
Prophylactic lymph node excision may be considered either as primary management of SC or 
as sentinel lymph node biopsy in conjunction with wide local excision or Mohs micrographic 
surgery [2, 11]. None of these options are however supported by a sufficient body of 
evidence in the literature. 
Radiotherapy is more commonly used as an adjuvant than a primary treatment. In ocu-
lar SC, postsurgical local irradiation has been shown to improve local control and to result in 
satisfactory cosmetic outcomes [12, 13]. Less information is available on radiotherapy in 
extraocular varieties of the disease. Cases of this type have largely been confined to patients 
who were not candidates for surgery or had postexcision residual tumors or nodal 
metastases. While nodal radiotherapy does not currently have an established role, some 
institutions do utilize this option in high-risk patients (i.e. in cases with recurrent tumors 
and perineural invasion) [8]. 
Chemotherapy is not a recognized standard treatment in SC. Only few case reports are 
available on therapies that involved chemotherapy as induction treatment before surgery, 
sometimes with objective responses [14–16]. A combination regimen of 5-fluorouracil and 
cisplatin, which was tested as a presurgical neoadjuvant therapy, was found to induce rapid 
and complete clinical remission in one patient [15], while a partial response to neoadjuvant 
5-fluorouracil and carboplatin was achieved in another patient [16]. Beneficial results in 
more advanced cases include one partial response in lung metastases after 1 cycle of 
carboplatin, docetaxel and bevacizumab [8]. On the other hand, a combination of cisplatin 
and gemcitabin or docetaxel and 5-fluorouracil revealed no efficacy in other metastatic 
patients [17], neither was a single-agent application of docetaxel capable of arresting 
metastatic progression [10]. Similar to a case reported by Priyadarshini et al. [15], we 
achieved complete clinical and radiographic remission by administration of 5-fluorouracil, 
cisplatin and docetaxel (followed by capecitabine as maintenance therapy) in a rapidly 
progressing tumor. At this time, the remission has been stable for over 20 months, with no 
need for additional surgery. 
Conclusion 
In this report, we have presented a case of aggressive extraocular SC that dramatically 
responded to chemotherapy after a series of multiple recurrences had kept emerging despite 
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several large excisions and radiotherapy. Being an extremely rare malignancy, unequivocal 
recommendations for the management of advanced SC do not exist. We propose testing the 
combination of 5-fluorouracil, cisplatin and docetaxel in a larger patient population 
characterized by advanced disease or as a neoadjuvant strategy for tumors not amenable to 
surgery without inflicting major mutilation. 
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Fig. 1. a Right retroauricular zone before chemotherapy. b Right retroauricular zone after chemotherapy. 
 
 
 
Fig. 2. a MRI before chemotherapy. Note the subcutaneous masses in the right retroauricular and parietal 
regions. b MRI after chemotherapy. No residual lesions are visible. 
 
